2

Expanded Materials and Methods
Experimental Animals: Male C57BL/6J (wild-type) mice, heterozygous Akt1 (Akt1+/-) mice, homozygous Akt1 (Akt1-/-) mice (C57BL/6J-Akt1 tm1Mbb ), and homozygous eNOS (eNOS-/-) mice (C57BL/6J-Nos3 tm1Unc ) were obtained from Jackson Laboratory (Bar Harbor, ME). EPOtransgenic mice were provided by Dr. M. Gassmann (Vetsuisse Faculty, Zürich, Switzerland).
Mice were maintained on standard chow with free access to drinking water. 100 U/ml penicillin, and 100 µg/ml streptomycin, Gibco) for 18 hours at 37°C in a CO 2 incubator (5% CO 2 , Forma Scientific). 1 In separate experiments, aortas were preincubated either with 10
µmol/L chelerythrine chloride (all Sigma), 5 µmol/L AG490 (Biomol), or 5 µmol/L 4,5,6,7-tetrabromobenzotriazole (TBB, Calbiochem) for 1 hour prior incubation to and for the duration of EPO incubation. [1] [2] [3] [4] [5] After incubation, aortic rings were collected for assays. All inhibitors were
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EPO was diluted in PBS prior experiments.
In-Vivo Studies: Wild-type, Akt1+/-, Akt1-/-, and eNOS-/-mice were randomly distributed to a control group (PBS, Gibco) and an EPO group (recombinant human EPO alpha, 1000 U/kg body weight, biweekly, s.c.). The dose of EPO was selected based on previous pharmacokinetic studies in mice. 6,7 After 14 days of treatment the animals were euthanized (pentobarbital, 60 mg/kg, i.p.) and aortas and lungs were harvested. In separate experiments, wild-type mice were treated for 3 days with PBS or EPO (1000 U/kg body weight, s.c.) once daily.
Systolic Blood Pressure:
Mice were trained for blood pressure measurement as described 8 and systolic blood pressure (SBP) was recorded in quiescent mice by a tail-cuff method (Harvard Apparatus Ltd., Kent, England) before and on fourteenth day of treatment. Fullerton, CA) in 5% methanol/95% water and fluorescence detection (Jasco; Japan) as described
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Measurement of GTPCH I Enzyme Activity:
Tissue supernatant homogenates were filtered using a Sephadex G25M column (Amersham; Piscataway, NJ) to remove endogenous neopterin, BH 4 , and phenylalanine. GTPCH I enzymatic activity was assayed using reverse-phase HPLC method by measurements of neopterin, which derived from dihydroneopterin triphosphate after oxidation and phosphate treatment. 10 The results were normalized against tissue protein levels. 
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